{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T20:27:07Z","timestamp":1783110427737,"version":"3.54.6"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2019,6,10]],"date-time":"2019-06-10T00:00:00Z","timestamp":1560124800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,6,10]],"date-time":"2019-06-10T00:00:00Z","timestamp":1560124800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"MEXT Japan","award":["MEXT-Supported Program for the Strategic Research Foundation at Private Universities (2011-2015)"],"award-info":[{"award-number":["MEXT-Supported Program for the Strategic Research Foundation at Private Universities (2011-2015)"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Oncol"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1007\/s12032-019-1289-6","type":"journal-article","created":{"date-parts":[[2019,6,10]],"date-time":"2019-06-10T06:02:27Z","timestamp":1560146547000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Forced expression of NR4A3 induced the differentiation of human neuroblastoma-derived NB1 cells"],"prefix":"10.1007","volume":"36","author":[{"given":"Takayuki","family":"Hirano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eri","family":"Nagasaki-Maeoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiaki","family":"Ishizuka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Takatori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yosuke","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reina","family":"Hoshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinsuke","family":"Yoshizawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Kawashima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shota","family":"Uekusa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiminobu","family":"Sugito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuichiro","family":"Uehara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noboru","family":"Fukuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroki","family":"Nagase","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tadateru","family":"Takayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masayoshi","family":"Soma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsugumichi","family":"Koshinaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1751-7968","authenticated-orcid":false,"given":"Kyoko","family":"Fujiwara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,6,10]]},"reference":[{"issue":"9579","key":"1289_CR1","doi-asserted-by":"publisher","first-page":"2106","DOI":"10.1016\/S0140-6736(07)60983-0","volume":"369","author":"JM Maris","year":"2007","unstructured":"Maris JM, Hogarty MD, Bagatell R, Cohn SL. Neuroblastoma. Lancet. 2007;369(9579):2106\u201320.","journal-title":"Lancet"},{"issue":"1","key":"1289_CR2","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1002\/cncr.29706","volume":"122","author":"KR Bosse","year":"2016","unstructured":"Bosse KR, Maris JM. Advances in the translational genomics of neuroblastoma: from improving risk stratification and revealing novel biology to identifying actionable genomic alterations. Cancer. 2016;122(1):20\u201333.","journal-title":"Cancer"},{"issue":"4","key":"1289_CR3","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1002\/mpo.2950240402","volume":"24","author":"H Caron","year":"1995","unstructured":"Caron H. Allelic loss of chromosome 1 and additional chromosome 17 material are both unfavourable prognostic markers in neuroblastoma. Med Pediatr Oncol. 1995;24(4):215\u201321.","journal-title":"Med Pediatr Oncol"},{"issue":"21","key":"1289_CR4","doi-asserted-by":"publisher","first-page":"2243","DOI":"10.1056\/NEJMoa052399","volume":"353","author":"EF Attiyeh","year":"2005","unstructured":"Attiyeh EF, London WB, Mosse YP, Wang Q, Winter C, Khazi D, McGrady PW, Seeger RC, Look AT, Shimada H, Brodeur GM, Cohn SL, Matthay KK, Maris JM. Chromosome 1p and 11q deletions and outcome in neuroblastoma. N Engl J Med. 2005;353(21):2243\u201353.","journal-title":"N Engl J Med"},{"issue":"8","key":"1289_CR5","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1161\/ATVBAHA.109.191163","volume":"30","author":"Y Zhao","year":"2010","unstructured":"Zhao Y, Bruemmer D. NR4A orphan nuclear receptors: transcriptional regulators of gene expression in metabolism and vascular biology. Arterioscler Thromb Vasc Biol. 2010;30(8):1535\u201341.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"12","key":"1289_CR6","doi-asserted-by":"publisher","first-page":"3223","DOI":"10.1158\/1078-0432.CCR-11-2953","volume":"18","author":"HM Mohan","year":"2012","unstructured":"Mohan HM, Aherne CM, Rogers AC, Baird AW, Winter DC, Murphy EP. Molecular pathways: the role of NR4A orphan nuclear receptors in cancer. Clin Cancer Res. 2012;18(12):3223\u20138.","journal-title":"Clin Cancer Res"},{"issue":"1","key":"1289_CR7","doi-asserted-by":"publisher","first-page":"38","DOI":"10.2174\/1389450115666141120112818","volume":"16","author":"K Wenzl","year":"2015","unstructured":"Wenzl K, Troppan K, Neumeister P, Deutsch AJ. The nuclear orphan receptor NR4A1 and NR4A3 as tumor suppressors in hematologic neoplasms. Curr Drug Targets. 2015;16(1):38\u201346.","journal-title":"Curr Drug Targets"},{"issue":"17","key":"1289_CR8","first-page":"5401","volume":"63","author":"AJ Wilson","year":"2003","unstructured":"Wilson AJ, Arango D, Mariadason JM, Heerdt BG, Augenlicht LH. TR3\/Nur77 in colon cancer cell apoptosis. Cancer Res. 2003;63(17):5401\u20137.","journal-title":"Cancer Res"},{"issue":"5","key":"1289_CR9","doi-asserted-by":"publisher","first-page":"2676","DOI":"10.1074\/jbc.M507752200","volume":"281","author":"VR Holla","year":"2006","unstructured":"Holla VR, Mann JR, Shi Q, DuBois RN. Prostaglandin E2 regulates the nuclear receptor NR4A2 in colorectal cancer. J Biol Chem. 2006;281(5):2676\u201382.","journal-title":"J Biol Chem"},{"issue":"4","key":"1289_CR10","doi-asserted-by":"publisher","first-page":"R51","DOI":"10.1186\/bcr2610","volume":"12","author":"AN Alexopoulou","year":"2010","unstructured":"Alexopoulou AN, Leao M, Caballero OL, Da Silva L, Reid L, Lakhani SR, Simpson AJ, Marshall JF, Neville AM, Jat PS. Dissecting the transcriptional networks underlying breast cancer: NR4A1 reduces the migration of normal and breast cancer cell lines. Breast Cancer Res. 2010;12(4):R51.","journal-title":"Breast Cancer Res"},{"issue":"2","key":"1289_CR11","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1002\/cncr.24737","volume":"116","author":"T Inamoto","year":"2010","unstructured":"Inamoto T, Czerniak BA, Dinney CP, Kamat AM. Cytoplasmic mislocalization of the orphan nuclear receptor Nurr1 is a prognostic factor in bladder cancer. Cancer. 2010;116(2):340\u20136.","journal-title":"Cancer"},{"issue":"3","key":"1289_CR12","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1124\/mol.109.061143","volume":"77","author":"SD Cho","year":"2010","unstructured":"Cho SD, Lee SO, Chintharlapalli S, Abdelrahim M, Khan S, Yoon K, Kamat AM, Safe S. Activation of nerve growth factor-induced B alpha by methylene-substituted diindolylmethanes in bladder cancer cells induces apoptosis and inhibits tumor growth. Mol Pharmacol. 2010;77(3):396\u2013404.","journal-title":"Mol Pharmacol"},{"key":"1289_CR13","doi-asserted-by":"publisher","first-page":"1733","DOI":"10.2147\/OTT.S66692","volume":"7","author":"ZY Yuan","year":"2014","unstructured":"Yuan ZY, Dai T, Wang SS, Peng RJ, Li XH, Qin T, Song LB, Wang X. Overexpression of ETV4 protein in triple-negative breast cancer is associated with a higher risk of distant metastasis. OncoTargets Ther. 2014;7:1733\u201342.","journal-title":"OncoTargets Ther."},{"issue":"1","key":"1289_CR14","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1038\/s41467-018-08069-x","volume":"10","author":"F Haller","year":"2019","unstructured":"Haller F, Bieg M, Will R, Korner C, Weichenhan D, Bott A, Ishaque N, Lutsik P, Moskalev EA, Mueller SK, Bahr M, Woerner A, Kaiser B, Scherl C, Haderlein M, Kleinheinz K, Fietkau R, Iro H, Eils R, Hartmann A, Plass C, Wiemann S, Agaimy A. Enhancer hijacking activates oncogenic transcription factor NR4A3 in acinic cell carcinomas of the salivary glands. Nat Commun. 2019;10(1):368.","journal-title":"Nat Commun."},{"issue":"8","key":"1289_CR15","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1038\/ng.185","volume":"40","author":"PG Rosengren","year":"2008","unstructured":"Rosengren PG, Golovko A, Sundstrom E, Curik I, Lennartsson J, Seltenhammer MH, Druml T, Binns M, Fitzsimmons C, Lindgren G, Sandberg K, Baumung R, Vetterlein M, Stromberg S, Grabherr M, Wade C, Lindblad-Toh K, Ponten F, Heldin CH, Solkner J, Andersson L. A cis-acting regulatory mutation causes premature hair graying and susceptibility to melanoma in the horse. Nat Genet. 2008;40(8):1004\u20139.","journal-title":"Nat Genet"},{"issue":"6","key":"1289_CR16","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1038\/nm1579","volume":"13","author":"SE Mullican","year":"2007","unstructured":"Mullican SE, Zhang S, Konopleva M, Ruvolo V, Andreeff M, Milbrandt J, Conneely OM. Abrogation of nuclear receptors Nr4a3 and Nr4a1 leads to development of acute myeloid leukemia. Nat Med. 2007;13(6):730\u20135.","journal-title":"Nat Med"},{"issue":"5","key":"1289_CR17","doi-asserted-by":"publisher","first-page":"1669","DOI":"10.3892\/ijo.2014.2340","volume":"44","author":"S Uekusa","year":"2014","unstructured":"Uekusa S, Kawashima H, Sugito K, Yoshizawa S, Shinojima Y, Igarashi J, Ghosh S, Wang X, Fujiwara K, Ikeda T, Koshinaga T, Soma M, Nagase H. Nr4a3, a possible oncogenic factor for neuroblastoma associated with CpGi methylation within the third exon. Int J Oncol. 2014;44(5):1669\u201377.","journal-title":"Int J Oncol"},{"key":"1289_CR18","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.abb.2018.09.013","volume":"660","author":"M Zhang","year":"2018","unstructured":"Zhang M, Wu J, Zhong W, Zhao Z, Liu Z. Long non-coding RNA BRE-AS1 represses non-small cell lung cancer cell growth and survival via up-regulating NR4A3. Arch Biochem Biophys. 2018;660:53\u201363.","journal-title":"Arch Biochem Biophys"},{"issue":"12","key":"1289_CR19","doi-asserted-by":"publisher","first-page":"2108","DOI":"10.1038\/s41388-018-0566-8","volume":"38","author":"O Fedorova","year":"2019","unstructured":"Fedorova O, Petukhov A, Daks A, Shuvalov O, Leonova T, Vasileva E, Aksenov N, Melino G, Barlev NA. Orphan receptor NR4A3 is a novel target of p53 that contributes to apoptosis. Oncogene. 2019;38(12):2108\u201322.","journal-title":"Oncogene"},{"issue":"1","key":"1289_CR20","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.cell.2012.03.003","volume":"149","author":"CV Dang","year":"2012","unstructured":"Dang CV. MYC on the path to cancer. Cell. 2012;149(1):22\u201335.","journal-title":"Cell"},{"issue":"18","key":"1289_CR21","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1056\/NEJM198510313131802","volume":"313","author":"RC Seeger","year":"1985","unstructured":"Seeger RC, Brodeur GM, Sather H, Dalton A, Siegel SE, Wong KY, Hammond D. Association of multiple copies of the N-myc oncogene with rapid progression of neuroblastomas. N Engl J Med. 1985;313(18):1111\u20136.","journal-title":"N Engl J Med"},{"issue":"4","key":"1289_CR22","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1200\/JCO.1991.9.4.581","volume":"9","author":"AT Look","year":"1991","unstructured":"Look AT, Hayes FA, Shuster JJ, Douglass EC, Castleberry RP, Bowman LC, Smith EI, Brodeur GM. Clinical relevance of tumor cell ploidy and N-myc gene amplification in childhood neuroblastoma: a Pediatric Oncology Group study. J Clin Oncol. 1991;9(4):581\u201391.","journal-title":"J Clin Oncol"},{"issue":"6","key":"1289_CR23","doi-asserted-by":"publisher","first-page":"2507","DOI":"10.3892\/ol.2015.3088","volume":"9","author":"XX Ke","year":"2015","unstructured":"Ke XX, Zhang D, Zhao H, Hu R, Dong Z, Yang R, Zhu S, Xia Q, Ding HF, Cui H. Phox2B correlates with MYCN and is a prognostic marker for neuroblastoma development. Oncol Lett. 2015;9(6):2507\u201314.","journal-title":"Oncol Lett."},{"issue":"6468","key":"1289_CR24","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1038\/368246a0","volume":"368","author":"RJ Smeyne","year":"1994","unstructured":"Smeyne RJ, Klein R, Schnapp A, Long LK, Bryant S, Lewin A, Lira SA, Barbacid M. Severe sensory and sympathetic neuropathies in mice carrying a disrupted Trk\/NGF receptor gene. Nature. 1994;368(6468):246\u20139.","journal-title":"Nature"},{"issue":"5","key":"1289_CR25","first-page":"1364","volume":"52","author":"A Nakagawara","year":"1992","unstructured":"Nakagawara A, Arima M, Azar CG, Scavarda NJ, Brodeur GM. Inverse relationship between trk expression and N-myc amplification in human neuroblastomas. Cancer Res. 1992;52(5):1364\u20138.","journal-title":"Cancer Res"},{"issue":"6001","key":"1289_CR26","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1038\/313404a0","volume":"313","author":"CJ Thiele","year":"1985","unstructured":"Thiele CJ, Reynolds CP, Israel MA. Decreased expression of N-myc precedes retinoic acid-induced morphological differentiation of human neuroblastoma. Nature. 1985;313(6001):404\u20136.","journal-title":"Nature"},{"issue":"2","key":"1289_CR27","doi-asserted-by":"publisher","first-page":"856","DOI":"10.2353\/ajpath.2009.090019","volume":"175","author":"G Alam","year":"2009","unstructured":"Alam G, Cui H, Shi H, Yang L, Ding J, Mao L, Maltese WA, Ding HF. MYCN promotes the expansion of Phox2B-positive neuronal progenitors to drive neuroblastoma development. Am J Pathol. 2009;175(2):856\u201366.","journal-title":"Am J Pathol"},{"issue":"10","key":"1289_CR28","doi-asserted-by":"publisher","first-page":"3244","DOI":"10.1158\/1078-0432.CCR-08-1815","volume":"15","author":"GM Brodeur","year":"2009","unstructured":"Brodeur GM, Minturn JE, Ho R, Simpson AM, Iyer R, Varela CR, Light JE, Kolla V, Evans AE. Trk receptor expression and inhibition in neuroblastomas. Clin Cancer Res. 2009;15(10):3244\u201350.","journal-title":"Clin Cancer Res"},{"issue":"2","key":"1289_CR29","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/S0166-2236(96)10072-2","volume":"20","author":"LI Benowitz","year":"1997","unstructured":"Benowitz LI, Routtenberg A. GAP-43: an intrinsic determinant of neuronal development and plasticity. Trends Neurosci. 1997;20(2):84\u201391.","journal-title":"Trends Neurosci"},{"issue":"9","key":"1289_CR30","doi-asserted-by":"publisher","first-page":"5503","DOI":"10.1523\/JNEUROSCI.14-09-05503.1994","volume":"14","author":"SM Strittmatter","year":"1994","unstructured":"Strittmatter SM, Igarashi M, Fishman MC. GAP-43 amino terminal peptides modulate growth cone morphology and neurite outgrowth. J Neurosci. 1994;14(9):5503\u201313.","journal-title":"J Neurosci"},{"issue":"11","key":"1289_CR31","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1002\/hipo.20486","volume":"18","author":"M Holahan","year":"2008","unstructured":"Holahan M, Routtenberg A. The protein kinase C phosphorylation site on GAP-43 differentially regulates information storage. Hippocampus. 2008;18(11):1099\u2013102.","journal-title":"Hippocampus"},{"issue":"3","key":"1289_CR32","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1002\/(SICI)1097-4652(200003)182:3<421::AID-JCP13>3.0.CO;2-2","volume":"182","author":"SN Kim","year":"2000","unstructured":"Kim SN, Kim SG, Park SD, Cho-Chung YS, Hong SH. Participation of type II protein kinase A in the retinoic acid-induced growth inhibition of SH-SY5Y human neuroblastoma cells. J Cell Physiol. 2000;182(3):421\u20138.","journal-title":"J Cell Physiol"},{"issue":"11","key":"1289_CR33","first-page":"1387","volume":"6","author":"A D\u2019Alessio","year":"1995","unstructured":"D\u2019Alessio A, De Vita G, Cali G, Nitsch L, Fusco A, Vecchio G, Santelli G, Santoro M, de Fransciscis V. Expression of the RET oncogene induces differentiation of SK-N-BE neuroblastoma cells. Cell Growth Differ. 1995;6(11):1387\u201394.","journal-title":"Cell Growth Differ"},{"issue":"20","key":"1289_CR34","doi-asserted-by":"publisher","first-page":"9070","DOI":"10.1128\/MCB.24.20.9070-9078.2004","volume":"24","author":"T Ponnio","year":"2004","unstructured":"Ponnio T, Conneely OM. nor-1 regulates hippocampal axon guidance, pyramidal cell survival, and seizure susceptibility. Mol Cell Biol. 2004;24(20):9070\u20138.","journal-title":"Mol Cell Biol"},{"issue":"3","key":"1289_CR35","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/0169-328X(94)90229-1","volume":"23","author":"BJ Eggen","year":"1994","unstructured":"Eggen BJ, Nielander HB, Rensen-de Leeuw MG, Schotman P, Gispen WH, Schrama LH. Identification of two promoter regions in the rat B-50\/GAP-43 gene. Brain Res Mol Brain Res. 1994;23(3):221\u201334.","journal-title":"Brain Res Mol Brain Res"},{"issue":"9","key":"1289_CR36","doi-asserted-by":"publisher","first-page":"3191","DOI":"10.1091\/mbc.11.9.3191","volume":"11","author":"CD Mobarak","year":"2000","unstructured":"Mobarak CD, Anderson KD, Morin M, Beckel-Mitchener A, Rogers SL, Furneaux H, King P, Perrone-Bizzozero NI. The RNA-binding protein HuD is required for GAP-43 mRNA stability, GAP-43 gene expression, and PKC-dependent neurite outgrowth in PC12 cells. Mol Biol Cell. 2000;11(9):3191\u2013203.","journal-title":"Mol Biol Cell"}],"container-title":["Medical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-019-1289-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12032-019-1289-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-019-1289-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,8]],"date-time":"2020-06-08T23:17:19Z","timestamp":1591658239000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12032-019-1289-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,10]]},"references-count":36,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["1289"],"URL":"https:\/\/doi.org\/10.1007\/s12032-019-1289-6","relation":{},"ISSN":["1357-0560","1559-131X"],"issn-type":[{"value":"1357-0560","type":"print"},{"value":"1559-131X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6,10]]},"assertion":[{"value":"27 April 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 May 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"66"}}